Kuala Lumpur AI MedTech: Pure Global on Malaysia's New Post-Market Surveillance Maze.

Artikel konnten nicht hinzugefügt werden

Leider können wir den Artikel nicht hinzufügen, da Ihr Warenkorb bereits seine Kapazität erreicht hat.

Der Titel konnte nicht zum Warenkorb hinzugefügt werden.

Bitte versuchen Sie es später noch einmal

Der Titel konnte nicht zum Merkzettel hinzugefügt werden.

Bitte versuchen Sie es später noch einmal

„Von Wunschzettel entfernen“ fehlgeschlagen.

Bitte versuchen Sie es später noch einmal

„Podcast folgen“ fehlgeschlagen

„Podcast nicht mehr folgen“ fehlgeschlagen

Kuala Lumpur AI MedTech: Pure Global on Malaysia's New Post-Market Surveillance Maze.

Jetzt kostenlos hören, ohne Abo

Details anzeigen

Über diesen Titel

This week on ASEAN MedTech Insights, we dissect the major regulatory shift in Malaysia. The Medical Device Authority (MDA) has just launched an aggressive new framework for post-market surveillance of AI-powered Software as a Medical Device (SaMD). This move signals a new era of accountability and presents both significant challenges and unique opportunities for companies in the digital health space. We explore the specific demands of these new guidelines, from continuous real-world data monitoring to cybersecurity reporting. We analyze the strategic implications for MedTech firms, looking at how this raises the bar for market entry and what it means for product lifecycle management. This isn't just a local story; it's a potential preview of what's to come for the entire ASEAN region as regulators get more sophisticated about AI. **Key Questions Answered:** * What are the specific new post-market requirements the Malaysian MDA has rolled out for AI software? * Why is Malaysia suddenly tightening the rules for AI-driven medical devices? * How does this change impact startups versus multinational MedTech companies? * What are the technical and financial hurdles in complying with these new surveillance demands? * Could Malaysia's new framework become the blueprint for other ASEAN countries? * What immediate steps should companies with SaMD products in Malaysia take? * How can you turn this new regulatory burden into a competitive advantage? At Pure Global, we specialize in helping MedTech and IVD companies navigate complex regulatory landscapes. We offer end-to-end solutions, from initial market access strategy and technical dossier submission to continuous post-market surveillance and local representation. Our blend of local expertise in over 30 markets and advanced AI tools ensures you can access and maintain your presence in key ASEAN markets efficiently. To streamline your global market access, contact Pure Global at info@pureglobal.com or visit https://pureglobal.com/.

Noch keine Rezensionen vorhanden